Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Endocrinology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Testoderm TTS CIII

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Alza
Approval Status: Approved December 1997
Treatment Area: testosterone deficiency

General Information

Testoderm TTS CIII has been approved for men with testosterone deficiency. It is a transdermal patch that delivers a 5-mg dose of testosterone during a 24-hour period.

Clinical Results

Clinical Results: Clinical trials showed that application of the Testoderm patch maintained normal serum testosterone levels, with delivery comparable to the normal circadian pattern of testosterone secretion.